SurgePays
SURG
#9947
Rank
S$47.99 M
Marketcap
S$2.28
Share price
1.73%
Change (1 day)
-4.27%
Change (1 year)

Revenue for SurgePays (SURG)

Revenue in 2025 (TTM): S$65.99 Million

According to SurgePays's latest financial reports the company's current revenue (TTM ) is S$65.27 Million. In 2024 the company made a revenue of S$82.75 Million a decrease over the revenue in the year 2023 that were of S$0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SurgePays from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$65.99 M-20.26%
2024 S$82.75 M-54.31%
2023 S$0.18 B11.16%
2022 S$0.16 B136.05%
2021 S$69.02 M-4.1%
2020 S$71.97 M107.39%
2019 S$34.7 M66.65%
2018 S$20.82 M988.96%
2017 S$1.91 M-59.92%
2016 S$4.77 M
2014 S$0 M22.31%
2013 S$0 M13.98%
2012 S$0 M-29.52%
2011 S$0 M-83.69%
2010 S$0.01 M16.24%
2009 S$0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
STAAR Surgical
STAA
S$0.29 B 357.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
S$2.12 B 3,161.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
S$5.24 B 7,931.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
S$31.59 B 48,301.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$119.41 B 182,834.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$73.05 B 111,810.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
CONMED
CNMD
S$1.74 B 2,575.01%๐Ÿ‡บ๐Ÿ‡ธ USA